Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,092 shares at $275.71 ($302K) on 2022-04-07, disclosed to the SEC on 2022-04-08.
Open-market sale of $302k VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.71 | 204 | $56K | 18.7% |
| 2 | $275.71 | 204 | $56K | 18.7% |
| 3 | $276.39 | 327 | $90K | 30.0% |
| 4 | $276.39 | 327 | $90K | 30.0% |
| 5 | $277.02 | 30 | $8K | 2.8% |
| Total | $276.15 avg | 1,092 |
| $302K |
| 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |